Primary Site >> Colorectal Cancer
Gene >> AKR1C3
|
|
|
|
|
|
|---|---|---|---|---|---|
|
Ref: Proteasome inhibitors MG-132 and bortezomib induce AKR1C1, AKR1C3, AKR1B1, and AKR1B10 in human colon cancer cell lines SW-480 and HT-29. PMID: 21215737 |
Ref: Expression of aldo-keto reductase family 1 member C3 (AKR1C3) in neuroendocrine tumors & adenocarcinomas of pancreas, gastrointestinal tract, and lung. PMID: 24228104 |
Ref: The disparate twins: a comparative study of CXCR4 and CXCR7 in SDF-1alpha-induced gene expression, invasion and chemosensitivity of colon cancer. PMID: 24255072 |
Ref: Expression of AKR1C3 and CNN3 as markers for detection of lymph node metastases in colorectal cancer. PMID: 24934327 Ref: An integrative approach for the identification of prognostic and predictive biomarkers in rectal cancer. PMID: 26359356 |
Ref: Sulforaphane Preconditioning Sensitizes Human Colon Cancer Cells towards the Bioreductive Anticancer Prodrug PR-104A. PMID: 26950072 Ref: Cytotoxic and pro-oxidative effects of Imperata cylindrica aerial part ethyl acetate extract in colorectal cancer in vitro. PMID: 27064015 Ref: Rational design of an AKR1C3-resistant analog of PR-104 for enzyme-prodrug therapy. PMID: 27453434 |
Ref: Identification of specific and common diagnostic antibody markers for gastrointestinal cancers by SEREX screening using testis cDNA phage library. PMID: 29719626 |